試す - 無料

Bio Spectrum - July 2018

filled-star
Bio Spectrum

Magzter GOLDで無制限に

読む Bio Spectrum 10,000以上の雑誌や新聞を1回の定期購読で購読できます  

カタログを見る

1ヶ月

$14.99

1年

$149.99

$12/month

(OR)

Bio Spectrumのみを購読する

この号を購入: July 2018

July 2018 から始まる 1 号

July 2018 から始まる 12 号

この号を購入する

$0.99

1年 $11.88

$7.99

Thanksgiving Sale!, ends on December 1, 2025

Please choose your subscription plan

いつでもキャンセルできます。

(義務なし) ⓘ

定期購読にご満足いただけない場合は、定期購読開始日から 7 日以内に help@magzter.com までメールをお送りいただければ、全額返金いたします。質問は一切ありません。お約束します! (注: 単号購入には適用されません)

デジタルサブスクリプション

即時アクセス ⓘ

今すぐ購読すると、Magzter の Web サイト、iOS、Android、Amazon アプリですぐに読み始めることができます。

安全性を確認済み

支払い ⓘ

Magzter は Authorize.Net の認定販売業者です。詳細はこちら

この号では

CORRECT THE GENETIC BURDEN
COVER
DESIGN BY:
Neha Metha
An estimated of 495,000 infants are born each year in India with congenital malformations, 21,400 with Down
syndrome, 9,000 with thalassemia, 5,200 with sickle cell disease, and 9,760 with amino acid disorders. Currently
the diagnostic and rehabilitation facilities are scarce and focused in certain limited locations but the effects of
these diseases are immense. Research shows that Genetic and congenital abnormality in India is the second
most common cause of infant and childhood mortality and occurs with a prevalence of 25-60 per 1000 births.
The growing burden of Genetic Disorders may be multifactorial in origin, comprising of climate changes,
environmental pollution, later age for conceiving a baby, hectic lifestyles etc. But this can be curbed by making
genetic testing centres easily accessible for expecting couples as and when needed. Currently, government has
adopted universal screening for Congenital Hearing Deficit in the state of Kerala. Also, Goa Government had
started the universal screening for all newborns for Congenital Metabolic Problems. But similar programmes
are needed across the country to deal with the outset as early as possible.
20

Bio Spectrum Description:

India's leading publication that covers the business of bio-technology. With comprehensive analyses of policy issues, products and services across the bio-pharma, bio-informatics, bio-infrastructure and bio-agriculture segments, it is the industry's most authoritative source of information.

最近の問題

  • March 2013

    March 2013

関連タイトル

人気カテゴリー